£

Wegovy

 
Maximum Quantity Allowed:
0.25mg
0.5mg
1mg
1.7mg
2.4mg
1 Pen
£

Wegovy (semaglutide) Weight Loss Injectable is a prescription medication used to help adults with obesity or overweight (with weight-related medical problems) lose weight and keep it off. It is an injectable GLP-1 receptor agonist that works by mimicking the effects of a natural hormone (GLP-1), which helps regulate appetite, slows digestion, and increases feelings of fullness, leading to reduced calorie intake.

Product supplied may be from a different manufacturer

Fastest delivery:
Order by 12:00pm

  • Free delivery over £50

    Fast, tracked delivery from £2.95. Arrives as quickly as the next working day in discreet packaging.

  • 100% UK-based pharmacy

    Our team of doctors and prescribers, and our support staff, are all UK-based.

  • Free support and advice

    We're on hand to offer free support and advice by email and telephone (Mon - Fri 09:00 - 17:30).  

  • Rated 4.3 out of 5

    based on 20 Google reviews.  

Description

What is Wegovy?

Wegovy is a brand-name prescription medication containing semaglutide, used primarily for chronic weight management in adults who are obese or overweight with at least one weight-related health condition. It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. Wegovy works by mimicking a natural hormone in the body that regulates appetite and food intake, helping patients feel fuller for longer and reducing overall calorie consumption. It is administered as a once-weekly injection and has been shown in clinical trials to produce significant and sustained weight loss when used alongside a reduced-calorie diet and increased physical activity.

How Does Wegovy Work?

Wegovy works by activating the GLP-1 receptors in the brain and body, which play a key role in regulating appetite and blood sugar levels. The active ingredient semaglutide mimics the natural GLP-1 hormone, which is released after eating. By activating these receptors, Wegovy slows the rate at which food leaves the stomach, reduces appetite and food cravings, lowers blood sugar levels by stimulating insulin release, and reduces the amount of glucose produced by the liver. This combination of effects helps patients feel fuller for longer, consume fewer calories, and achieve sustained weight loss over time.

Warnings

Do not use if you:

  • Are allergic to semaglutide or any of the ingredients in Wegovy.
  • Have a personal or family history of medullary thyroid carcinoma (a type of thyroid cancer).
  • Have multiple endocrine neoplasia syndrome type 2 (MEN 2).
  • Are pregnant, planning to become pregnant, or breastfeeding.

 

Consult a doctor before use if you:

  • Have a history of pancreatitis, gallbladder problems, or kidney disease.
  • Are taking other medications for diabetes, as Wegovy may lower blood sugar levels.
  • Have or are at risk of developing depression or suicidal thoughts.

 

Discontinue use and seek medical attention if:

  • You experience severe stomach pain, nausea, or vomiting (these may be signs of pancreatitis).
  • You notice a lump or swelling in your neck or have difficulty swallowing (this may indicate thyroid issues).
  • You experience symptoms of low blood sugar, such as dizziness, confusion, or fainting.

 

Keep out of reach of children: Wegovy is a prescription medication and should not be used by individuals for whom it is not prescribed.

Not for use in children: Wegovy has not been studied in individuals under 18 years of age and is not approved for pediatric use.

Directions

Dosage:

Wegovy is administered as a once-weekly injection, typically starting with a low dose and gradually increasing as directed by your healthcare provider. This allows the body to adjust and minimize side effects.

Administration:

Inject the medication under the skin (subcutaneous injection) in the abdomen, thigh, or upper arm. Rotate injection sites each week to avoid irritation. Your healthcare provider will guide you on how to self-administer the injections.

Take with or without food:

Wegovy does not need to be taken with meals, but you should maintain a healthy, reduced-calorie diet and exercise regularly for best results.

Do not exceed the prescribed dose:

Follow your healthcare provider’s instructions carefully. If you miss a dose, take it as soon as possible unless it’s close to your next scheduled dose. Never double up doses.

Store properly:

Keep Wegovy in the refrigerator until ready for use. Once opened, it can be kept at room temperature for a limited time, as advised by your healthcare provider.

Ingredients

Active Ingredient:

  • Semaglutide (500mcg or 1mg per dose): A GLP-1 receptor agonist that regulates appetite and helps reduce food intake.

Inactive Ingredients:

  • Disodium phosphate dihydrate
  • Sodium chloride
  • Water for injections
  • Hydrochloric acid and/or sodium hydroxide (for pH adjustment)

 

These ingredients ensure the stability and proper administration of the active compound.

Side Effects

Common Side Effects:

  1. Nausea: Frequently reported, especially during the initial weeks of treatment.
  2. Diarrhea or constipation: Digestive upset may occur but typically improves over time.
  3. Vomiting: May happen in response to appetite suppression and changes in eating habits.

Less Common but Serious Side Effects:

  1. Pancreatitis: Symptoms include severe stomach pain, nausea, and vomiting. Seek immediate medical attention if these occur.
  2. Gallbladder problems: Including gallstones, which can cause pain in the upper right abdomen and shoulder.
  3. Low blood sugar: Particularly when used with other medications for diabetes.

Rare Side Effects:

  1. Kidney problems: Reduced urine output or swelling in the hands and feet could indicate kidney issues.
  2. Thyroid tumors: In rare cases, WeGovy has been associated with thyroid tumors, so report any neck swelling or difficulty swallowing to your doctor.
  3. Depression or suicidal thoughts: Report any changes in mood or behavior immediately.

FAQs

1. How does Wegovy help with weight loss?

Wegovy contains semaglutide, a GLP-1 receptor agonist that helps reduce appetite, increase feelings of fullness, and slow down digestion. This leads to reduced calorie intake and, ultimately, weight loss.

2. How long does it take to see results with Wegovy?

Many users begin to see noticeable weight loss within the first few weeks of treatment, but significant results are usually seen over a few months when combined with a healthy diet and exercise. It is important to follow your healthcare provider's guidance for best results.

3. How is Wegovy administered?

Wegovy is a once-weekly injection that can be self-administered under the skin (subcutaneous injection) in areas such as the abdomen, thigh, or upper arm. Your healthcare provider will show you how to properly use the injection pen.

4. Are there any side effects?

Common side effects include nausea, vomiting, diarrhea, and constipation, particularly in the early stages of treatment. These usually decrease over time as your body adjusts. Rare but serious side effects include gallbladder problems, pancreatitis, and kidney issues.

5. Can anyone use Wegovy for weight loss?

Wegovy is intended for adults with a BMI of 30 or higher, or a BMI of 27 or higher with weight-related conditions such as high blood pressure, type 2 diabetes, or high cholesterol. It should not be used by individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2.